Salivary caffeine in Parkinson’s disease

Salivary caffeine in Parkinson’s disease

Abstract We aimed to investigate salivary caffeine content, caffeine absorption and metabolism in Parkinson’s disease (PD) and verify whether salivary caffeine can be used as a biomarker of PD. We enrolled 98 PD patients and 92 healthy subjects. Caffeine and its major metabolite, paraxanthine, were...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, Alessia Ciogli, Andrea Fabbrini, Matteo Costanzo, Simone Manetto, Antonella Conte, Claudio Villani, Giovanni Fabbrini, Alfredo Berardelli
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a18969ffd7364c09aa30c41879aa4f47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a18969ffd7364c09aa30c41879aa4f47

Ejemplares similares